Drugs / Vivotif
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03312699 | Sep 2017 → Dec 2023 | hepatitis A virus infection, influenza, typhoid fever | Stanford University | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00751933 | Oct 2008 → Oct 2009 | ulcerative colitis | Haukeland University Hospital | Terminated | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT06104345 | Oct 2023 → Jun 2024 | cholera, typhoid fever | Helsinki University Central Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03705585 | Nov 2018 → May 2029 expected | — | University of Maryland, Baltimore | Recruiting | No outcome recorded |
| Phase 4 | NCT02121145 | Oct 2013 → Dec 2019 | — | Helsinki University Central Hospital | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03971669 Background | Jan 2004 → Jun 2030 expected | — | University of Maryland, Baltimore | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vivotif | “Oral typhoid fever vaccine (Vivotif®) on Days 0, 2 and 4.” NCT06104345 ↗ |
| Modality | Vaccine | “Vaccine Vivotif + Vaccine Dukoral + oats” NCT00751933 ↗ |
| Route | Oral | “One capsule is to be swallowed approximately 1 hour before a meal” NCT03312699 ↗ |